-
1 . Academic Journal
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
- 저자
- by Cahn, PE; Cassetti, I; Losso, M; Bloch, MT; Roth, N, et al.
- 소스
- In The Lancet HIV November 2017 4(11):e486-e494